Evidence map›Paper›PMID 35445738›Full record

ArticleInternational journal of oncology2022

The impact of radiation therapy on the TCR Vβ chain repertoire in patients with prostate cancer.

Maria Goulielmaki, Nikolaos Davanos, Paraskevi Kogionou, Panagiota Batsaki, Savvas Stokidis, Maria Adamaki, Eftychia Mosa, Evanthia Vasilakou, Charalambos Zambatis, Angelos D Gritzapis and 3 more

Abstract read
In one paragraph

Article in International journal of oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Maria GoulielmakiCancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, 11522 Athens, Greece.
Nikolaos DavanosANTISEL S.A., 11527 Athens, Greece.
Paraskevi KogionouCancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, 11522 Athens, Greece.
Panagiota BatsakiCancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, 11522 Athens, Greece.
Savvas StokidisCancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, 11522 Athens, Greece.
Maria AdamakiBiomedical Applications Unit, Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece.
Eftychia MosaDepartment of Radiation Oncology, Saint Savas Cancer Hospital, 11522 Athens, Greece.
Evanthia VasilakouDepartment of Radiation Oncology, Saint Savas Cancer Hospital, 11522 Athens, Greece.
Charalambos ZambatisDepartment of Radiation Oncology, Saint Savas Cancer Hospital, 11522 Athens, Greece.
Angelos D GritzapisCancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, 11522 Athens, Greece.
Vassilios ZoumpourlisBiomedical Applications Unit, Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece.
Constantin N BaxevanisCancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, 11522 Athens, Greece.
Sotirios P FortisCancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, 11522 Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiation therapy (RT) is an essential component in the therapeutic treatment of patients with localized prostate cancer (LPCa). Besides its local effects, ionizing radiation has been linked to mechanisms leading to systemic immune activation. The present study explored the effect of RT on the T‑cell receptor variable β (TCR Vβ) chain repertoire of peripheral blood T cells in patients with LPCa. High‑throughput TCR Vβ sequencing was performed on 20 blood samples collected from patients with LPCa at baseline and 3 months post‑RT. The diversity index was altered, as were TCR Vβ clonal evenness and convergence before and post‑RT; however, these findings were not significant. Notably, marked changes in the frequencies among the top 10 TCR Vβ clonotypes were detected and some patients developed new clonotypes of high abundance. These data provided initial evidence that RT in patients with LPCa may induce systemic immune changes, which could be exploited by future therapies for improved clinical results.

Indexed as

Prostatic NeoplasmsReceptors, Antigen, T-Cell, alpha-betaHumansMaleReceptors, Antigen, T-Cell, alpha-betaclonotype frequenciesprostate cancerradiation therapyT cellT‑cell receptor variable β

Identifiers

PMID35445738
PMCPMC9084611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.